FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series D or later / Health care startups that raised Series D or later in Asia

Health care startups that raised Series D or later in Asia

Updated 16 Nov 2026

Reset
Health care startups that raised Series D or later in Asia
One-time CSV
  • 223 funded companies, 175 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-d-plus~asia.csv223 rows × 18 columns
CompanyCityLast roundAmountDate
Barty MedicalHangzhouSeries D$29.5M2026-09-23
Kai MedtechMinhangSeries D$73.9M2026-07-28
VivolightNanshanquSeries E$13.9M2026-06-01
Full-Life TechnologiesShanghaiSeries D$109.0M2026-05-18
AidocTel AvivSeries E$150.0M2026-04-29
New Radiomedicine TechnologyChengduSeries E$145.4M2026-04-03
Cult.fitBangaloreSeries G$46.8M2026-03-21
CORXEL PharmaceuticalsShanghaiSeries D$287.0M2026-01-22

8 rows of the CSV in 5 of its 18 columns.

223
Startups
$21.1B
Total raised
26
Funded in the last 12 months
$1.6B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 223
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Barty Medical Barty Medical provides hospital healthcare services to patients. Health care Hangzhou, China Series D $29.5M 2026-09-23 $46.7M Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund 101 to 250 2015
Kai Medtech Kai Medtech markets and sells vascular intervention medical devices. Health care Minhang, China Series D $73.9M 2026-07-28 $105.3M Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 51 to 100 2019
Vivolight Vivolight conducts medical research and develops intravascular interventional imaging technology. Biotech Nanshanqu, China Series E $13.9M 2026-06-01 $52.2M CAS Star, TusStar 51 to 100 2012
Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Shanghai, China Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
Aidoc Aidoc develops artificial intelligence software for healthcare imaging and clinical workflows. Artificial intelligence Tel Aviv, Israel Series E $150.0M 2026-04-29 $564.0M General Catalyst, TCV, TLV Partners +2 251 to 500 2016
New Radiomedicine Technology New Radiomedicine Technology supplies medical isotopes in China. Biotech Chengdu, China Series E $145.4M 2026-04-03 $330.6M Chengdu Science and Technology Venture Capital 101 to 250 2016
Cult.fit Unicorn Cult.fit offers digital and offline health services covering fitness, nutrition, and mental well-being. Health care Bangalore, India Series G $46.8M 2026-03-21 $683.6M Accel, InnoVen Capital 501 to 1,000 2016
CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Shanghai, China Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
Surgerii Technology Surgerii Technology develops minimally invasive surgical robots. Hardware Haidian, China Series D $100.0M 2025-12-31 $100.0M Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 11 to 50 2014
MAXVAX MAXVAX develops and commercializes novel vaccines. Biotech Shuangliu, China Series D $27.4M 2025-12-25 $284.2M IDG Capital, Shenzhen Capital Group, Korea Investment Partners +1 251 to 500 2016
The Sleep Company The Sleep Company develops a mattress that adapts to its user's body shape. Health care Mumbai, India Series D $54.7M 2025-08-06 $81.7M Alteria Capital, Fireside Ventures, Premji Invest +1 1,001 to 5,000 2019
METiS Pharmaceuticals METiS Pharmaceuticals is an AI-driven drug formulation company. Artificial intelligence Hangzhou, China Series D $55.7M 2025-08-04 $391.7M Source Code Capital, Frees Fund, Luminous Ventures (former Lightspeed China Partners) 51 to 100 2020
Weimai Weimai uses big data and artificial intelligence to digitize its healthcare service platform. Artificial intelligence Yuhang, China Series D $27.3M 2025-01-07 $257.3M IDG Capital, Matrix Partners China, Source Code Capital +1 101 to 250 2013
IMPACT Therapeutics IMPACT Therapeutics develops similar drugs to treat cancer. Biotech Nanjing, China Series D $34.6M 2024-11-15 BioVenture, Lilly Asia Ventures, Decheng Capital +2 51 to 100 2009
DK MedTech DK MedTech manufactures vascular interventional medical device products. Health care Suzhou, China Series E $24.5M 2024-06-21 $36.2M Qiming Venture Partners, Legend Capital, Oriza Seed Capital (Oriza Yuandian) +1 251 to 500 2015
Yidao Biotechnology Yidao Biotechnology researches and develops vaccines and biomedical products. Biotech Suzhou, China Series D $25.2M 2024-05-09 Qiming Venture Partners, Northern Light Venture Capital 2017
Alodokter Alodokter is a digital health platform offering telemedicine and doctor consultations to patients. Health care Jakarta, Indonesia Series D $5.2M 2024-02-21 $53.3M 500 Global, Samsung Ventures, Golden Gate Ventures +2 251 to 500 2014
Rehab Rehab provides information and communication technology and digital services for the medical care field. Health care Tokyo, Japan Series D $6.7M 2024-02-16 $24.4M Global Brain Corporation, Mitsubishi UFJ Capital, SMBC Venture Capital +2 101 to 250 2016
Clove Dental Clove Dental is a dental chain providing end-to-end oral healthcare services. Health care New Delhi, India Series E $50.1M 2023-11-24 $117.0M Investcorp, SPDG, Qatar Investment Authority +1 1,001 to 5,000 2011
Atom Bioscience & Pharmaceutical Atom Bioscience is a clinical-stage biotechnology company. Biotech Suzhou, China Series D $82.1M 2023-10-16 Fortune Venture Capital, Oriza Holdings, Kaitai Capital +1 11 to 50 2012
Halodoc Halodoc is a health-tech platform that connects patients with doctors, insurers, labs, and pharmacies. Fintech Jakarta, Indonesia Series D $100.0M 2023-07-28 $245.0M Korea Investment Partners, Bill & Melinda Gates Foundation, Gojek 501 to 1,000 2016
Landing Medical High Technology Landing Medical High Technology develops AI-driven diagnostic technology for cervical cancer screening. Artificial intelligence Wuhan, China Series D $50.1M 2021-11-10 $50.1M China Merchants Venture Capital, Dalton Venture, Sangel Capital 251 to 500 2000
Shukun Technology Shukun Technology develops AI diagnostic systems for chronic diseases in China. Artificial intelligence Beijing, China Series D $105.8M 2021-08-17 $296.4M Qiming Venture Partners, Goldman Sachs, 5Y Capital +1 501 to 1,000 2017
Infervision Infervision uses deep learning and computer vision to help diagnose cancers. Artificial intelligence Beijing, China Series D $140.0M 2021-07-23 $214.7M Sequoia Capital, Qiming Venture Partners, CDH Investments +1 51 to 100 2015
Atonarp Atonarp analyzes chemical composition by combining molecular science with data processing algorithms. Energy Tokyo, Japan Series D $50.0M 2021-05-18 $101.5M SMBC Venture Capital, SBI Investment, Venture Labo Investment +1 51 to 100 2009
Supermonkey Supermonkey develops and operates a mobile app that provides fitness services. Health care Shenzhen, China Series E $15.5M 2021-05-06 CICC, PreAngel, Fosun RZ Capital +1 51 to 100 2014
Keep Unicorn Keep is a mobile fitness community offering training programs for different groups of people. Education Beijing, China Series F $360.0M 2021-01-10 Goldman Sachs, Hillhouse Investment, Coatue +1 501 to 1,000 2014
DXY Unicorn DXY is an online healthcare community connecting doctors, consumers, and healthcare organizations. Biotech Hangzhou, China Series E $500.0M 2020-12-29 $682.0M Shunwei Capital, DCM Ventures, Legend Capital +1 101 to 250 2000
Practo Practo is an mhealth platform that connects patients with healthcare providers for appointments and consultations. Health care Bangalore, India Series D $32.0M 2020-08-15 $228.2M Sequoia Capital, Peak XV Partners, Thrive Capital +1 501 to 1,000 2008
XACT Robotics XACT Robotics develops a platform technology for robotic needle steering in minimally invasive interventional procedures. Hardware Caesarea, Israel Series D $36.0M 2019-11-13 Chasing Value Asset Management 51 to 100 2013

Table 1. Health care startups that raised Series D or later in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 223.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 CORXEL Pharmaceuticals CORXEL Pharmaceuticals develops medicines for underserved patients. Biotech Shanghai, China Series D $287.0M 2026-01-22 $451.8M Leaps by Bayer, RTW Investments 51 to 100 2019
2 Aidoc Aidoc develops artificial intelligence software for healthcare imaging and clinical workflows. Artificial intelligence Tel Aviv, Israel Series E $150.0M 2026-04-29 $564.0M General Catalyst, TCV, TLV Partners +2 251 to 500 2016
3 New Radiomedicine Technology New Radiomedicine Technology supplies medical isotopes in China. Biotech Chengdu, China Series E $145.4M 2026-04-03 $330.6M Chengdu Science and Technology Venture Capital 101 to 250 2016
4 Full-Life Technologies Full-Life Technologies develops, produces, and commercializes medicines for cancer therapy. Biotech Shanghai, China Series D $109.0M 2026-05-18 $337.3M Sky9 Capital, Chengwei Capital, Prosperity7 Ventures +1 51 to 100 2021
5 Surgerii Technology Surgerii Technology develops minimally invasive surgical robots. Hardware Haidian, China Series D $100.0M 2025-12-31 $100.0M Shunwei Capital, SDIC Venture Capital, Shanghai Biomedical Industrial Equity Investment Fund +1 11 to 50 2014
6 Kai Medtech Kai Medtech markets and sells vascular intervention medical devices. Health care Minhang, China Series D $73.9M 2026-07-28 $105.3M Shenzhen Capital Group, Wuxi Capital, Hengxu Capital +1 51 to 100 2019
7 Cult.fit Unicorn Cult.fit offers digital and offline health services covering fitness, nutrition, and mental well-being. Health care Bangalore, India Series G $46.8M 2026-03-21 $683.6M Accel, InnoVen Capital 501 to 1,000 2016
8 Barty Medical Barty Medical provides hospital healthcare services to patients. Health care Hangzhou, China Series D $29.5M 2026-09-23 $46.7M Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund 101 to 250 2015
9 MAXVAX MAXVAX develops and commercializes novel vaccines. Biotech Shuangliu, China Series D $27.4M 2025-12-25 $284.2M IDG Capital, Shenzhen Capital Group, Korea Investment Partners +1 251 to 500 2016
10 Vivolight Vivolight conducts medical research and develops intravascular interventional imaging technology. Biotech Nanshanqu, China Series E $13.9M 2026-06-01 $52.2M CAS Star, TusStar 51 to 100 2012

Table 2. Health care startups that raised Series D or later in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Qiming Venture Partners Venture capital firm Shanghai, China 6 3%
2 Matrix Partners China Venture capital firm Beijing, China 4 2%
3 Shenzhen Capital Group Venture capital firm Nanshan, China 3 1% 2 Kai Medtech, MAXVAX
4 IDG Capital Private equity firm Beijing, China 3 1% 1 MAXVAX
5 CICC Investment bank Beijing, China 3 1%
6 Source Code Capital Venture capital firm Chaoyang, China 3 1%
7 OurCrowd Venture capital firm Jerusalem, Israel 3 1%
8 BioVenture Venture capital firm Suzhou, China 3 1%
9 Eight Roads Ventures Venture capital firm London, United Kingdom 3 1%
10 SMBC Venture Capital Corporate venture arm Tokyo, Japan 3 1%
11 Global Brain Corporation Venture capital firm Tokyo, Japan 3 1%
12 CDH Investments Private equity firm Kowloon City, Hong Kong 3 1%
13 Northern Light Venture Capital Venture capital firm Beijing, China 3 1%
14 5Y Capital Venture capital firm Xuhui, China 3 1%
15 Sinowisdom Venture capital firm Hangzhou, China 2 1% 1 Barty Medical

Table 3. Health care startups that raised Series D or later in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 86 39% $7.2B
Software 42 19% $4.9B
Artificial intelligence 16 7% $2.2B
Hardware 12 5% $337.6M
Fintech 5 2% $876.7M
Commerce 4 2% $279.3M
Education 2 1%
Energy 1 0% $101.5M

Table 4. Health care startups that raised Series D or later in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series D+ 223 100% $38.7M

Table 5. Health care startups that raised Series D or later in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
China 166 74%
Israel 18 8%
Japan 16 7%
India 9 4%
South Korea 8 4%
Taiwan 3 1%
Indonesia 2 1%
Hong Kong 1 0%

Table 6. Health care startups that raised Series D or later in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Beijing 37 17%
Shanghai 30 13%
Tokyo 14 6%
Hangzhou 12 5%
Suzhou 12 5%
Shenzhen 10 4%
Haidian 6 3%
Guangzhou 6 3%
Tel Aviv 5 2%
Minhang 4 2%
Chengdu 4 2%
Bangalore 4 2%

Table 7. Health care startups that raised Series D or later in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 5 19% $283.0M
July 2026 2 8% $110.8M
June 2026 2 8% $60.8M
May 2026 2 8% $116.9M
April 2026 4 15% $424.6M
March 2026 4 15% $92.8M
January 2026 2 8% $294.7M
December 2025 5 19% $194.8M

Table 8. Health care startups that raised Series D or later in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 21 9% $1.4B
2025 27 12% $886.2M
2024 23 10% $221.4M
2023 18 8% $670.2M
2022 21 9% $1.1B
2021 36 16% $3.7B

Table 9. Health care startups that raised Series D or later in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 3 1%
2015 to 2019 70 31%
2010 to 2014 85 38%
Before 2010 65 29%

Table 10. Health care startups that raised Series D or later in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 3%
11 to 50 49 22%
51 to 100 52 24%
101 to 250 39 18%
251 to 500 25 11%
501 to 1,000 26 12%
1,001 to 5,000 17 8%
5,001 to 10,000 2 1%
10,001 or more 1 0%

Table 11. Health care startups that raised Series D or later in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Asia whose last round is Series D or later are on the list?
223, in the file dated 16 November 2026. 26 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 223 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series D or later in Asia: 223 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Asia

Other sectors that raised Series D or later in Asia

Cite: FundingWatcher, 223 health care companies in Asia whose most recent round is Series D or later, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-d-plus/asia/